-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

721A.O1.6 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities: Optimizing Conditioning and Donor Selection in Allogeneic Stem Cell Transplantation

Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Acute Myeloid Malignancies, AML, Research, Clinical trials, Lymphoid Leukemias, ALL, Combination therapy, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, Health outcomes research, T Cell lymphoma, Diseases, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Registries, Myeloid Malignancies, Survivorship, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Room 6B (San Diego Convention Center)
Moderators:
Tsiporah Shore, MD, FRCPC, FACP, Weill Cornell Medical College and MHD Monzr M. Al Malki, MD, City of Hope National Medical Center
Disclosures:
Shore: Bioline Rx: Consultancy. Al Malki: Incyte: Research Funding; Tscan: Consultancy; NexImmune: Consultancy, Research Funding; Tr1X: Consultancy; CareDx: Consultancy; Stemline therapeutics: Research Funding.
9:30 AM

Arnon Nagler, MD1, Allain-Thibeault Ferhat2*, Nicolaus Kröger, MD3*, Matthias Eder, MD4*, Gerard Socie5, Didier Blaise, MD, PhD6, Thomas Schroeder7*, Hélène Labussière-Wallet, MD8*, Johan Maertens, MD, PhD9*, Alessandro Busca, MD10*, Edouard Forcade, MD, PhD11*, Tobias Gedde-Dahl, MD12*, Alessandro Rambaldi13, Claude-Éric Bulabois, MD14*, Fabio Ciceri, MD15* and Mohamad Mohty, MD, PhD16,17

1Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
2EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
3University Hospital Eppendorf, Hamburg, Germany, Hamburg, Germany
4Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Hematology Transplantation, Paris, France
6Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
7Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
8Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France
9Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium
10SS Trapianto di Cellule Staminali, Torino, Italy
11Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hopital Haut-Leveque, Pessac, France
12Oslo University Hospital, Rikshospitalet, Oslo, Norway
13Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo, Italy
14Hematology Department, Grenoble University Hospital, Grenoble, France
15Ospedale San Raffaele, Haematology and BMT, Milano, Italy
16Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
17Acute Leukemia Working Party, Paris Study office, European Society for Blood and Marrow Transplantation, Paris, France

9:45 AM

Uday Popat, MD1, Roland L. Bassett, MS2*, Amin M. Alousi, MD1*, Gheath Alatrash, PhD, DO1, Yosra M. Aljawai, MD, MS1, Qaiser Bashir, MD1, George Chen, MD1, Warren B. Fingrut, MD1*, Chitra Hosing, MD1, Jin S. Im, MD, PhD1, Partow Kebriaei, MD1, David Marin, MD1, Yago Nieto, MD, PhD1, Amanda L. Olson, MD1, Betul Oran, MD, MS1, Muzaffar H. Qazilbash, MD1, Jeremy Ramdial, MD1, Neeraj Y. Saini, MD1, Portia Smallbone, MD1*, Samer A. Srour, MD1, Benigno C. Valdez, PhD1, Richard E. Champlin, MD1, Borje S. Andersson, MD, PhD1 and Elizabeth J. Shpall, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

10:00 AM

Yenny Alejandra Moreno Vanegas, MD, BSc1, Urshila Durani, MD, MPH2, Christine Goth, BS3*, Nandita Khera, MD4, Zhuo Li, MS5*, Hemant S. Murthy, MD1, Vivek Roy, MD6, James M. Foran, MD7, Ernesto Ayala, MD8, Mohamed A. Kharfan-Dabaja, MD, MBA8, Jasmine Zain, MD9 and Madiha Iqbal, MD10

1Mayo Clinic, Jacksonville, FL
2Division of Hematology, Mayo Clinic, Rochester, MN
3Hematology, City of Hope National Medical Center, Duarte, CA
4Mayo Clinic, Phoenix, AZ
5Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
6Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
7Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL
8Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
9City of Hope, Duarte, CA
10Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

10:15 AM

Eolia Brissot1,2, Myriam Labopin3*, Didier Blaise, MD, PhD4, Cristina Castilla-Llorente, MD5*, Annoek E. C. Broers, MD6*, Nicolaus Kröger, MD Prof7*, Jakob R. Passweg8, Andrew Bruce McDonald, MBBS9*, Lucía López-Corral10*, Zinaida Peric11*, Sebastian Giebel, MD, PhD12*, Arnon Nagler, MD13, Mohamad Mohty, MD, PhD14,15, Fabio Ciceri, MD16*, Francesca Kinsella17* and Ludovic Gabellier, MD, PhD18*

1Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France, Paris, France
2Service d’hématologie et des maladies du sang, Hôpital Saint-Antoine, NOGENT SUR MARNE, France
3EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
4Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille, France
5Gustave Roussy Cancer Campus, Villejuif, France
6Erasmus MC Cancer Institute, Rotterdam, Netherlands
7Department of Stem Cell Transplantation, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
8University Hospital Basel, Basel, Switzerland
9Alberts Cellular Therapy, Netcare Pretoria East Hospital, Pretoria, South Africa
10University Hospital of Salamanca, Salamanca, Spain
11Department of Haematology, University Hospital Centre Rijeka, Rijeka, Croatia
12Department of Hematology and Bone Marrow Transplantation, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland
13Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Aviv, Israel
14Sorbonne University, Hôpital Saint-Antoine, and INSERM UMRs938, Paris, France
15Hematology Dpt, Hopital Saint-Antoine, University UPMC, INSERM, Paris, France
16Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
17Birmingham Centre for Cellular Therapy and Transplant (BCCTT), Birmingham, United Kingdom
18Hematology Departement, CHU Montpellier University Hospital, UMR-CNRS 5535, Montpellier, France

10:30 AM

Boula Gattas, MD1*, Xia Bi, MD2*, Dolores Grosso, DNP1*, Alicia Bao, MD3*, Allison Gradone, MD1*, Brenda Grande1*, Gina Mateja1*, Arpona Dev Nath, MD4*, Joanne Filicko-O'Hara, MD2, William O'Hara, PharmD1*, John Wagner, MD1*, Neal Flomenberg, MD1* and Usama Gergis, MD, MBA2

1Thomas Jefferson University, Philadelphia
2Department of Bone Marrow Transplant and Cellular Therapy, Sidney Kimmel Cancer Center of Thomas Jefferson University, Philadelphia, PA
3Thomas Jefferson University, Philadelphia, PA
4Thomas Jefferson University Hospital, Philadelphia, PA

10:45 AM

Jeong-A Kim1, Jinhang Kim, MD2*, Nanyoung Yun3*, Misuk Yang2* and Youngeun Jung3*

1St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
2Department of Hematology, St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea, Republic of (South)
3St. Vincent Hospital, The Catholic University of Korea, Suwon, Korea, Republic of (South)

*signifies non-member of ASH